SPONSOR
Shenzhen Wingor Biotechnology Co., Ltd.
Total Trials
2
Recruiting
2
Phases
Phase 1, Phase 2, Phase 2
Shenzhen Wingor Biotechnology Co., Ltd. is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Premature Ovarian Insufficiency, Acute Ischemic Stroke AIS.
The trial portfolio spans Phase 1, Phase 2, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Shenzhen Wingor Biotechnology Co., Ltd.
How many clinical trials has Shenzhen Wingor Biotechnology Co., Ltd. sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Shenzhen Wingor Biotechnology Co., Ltd., of which 2 are actively recruiting participants. These trials cover conditions including Premature Ovarian Insufficiency, Acute Ischemic Stroke AIS. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Shenzhen Wingor Biotechnology Co., Ltd. research focus on?
Shenzhen Wingor Biotechnology Co., Ltd. clinical trials span Premature Ovarian Insufficiency, Acute Ischemic Stroke AIS. The research pipeline includes Phase 1, Phase 2, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Shenzhen Wingor Biotechnology Co., Ltd. clinical trial?
To participate in a Shenzhen Wingor Biotechnology Co., Ltd. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Shenzhen Wingor Biotechnology Co., Ltd. trials with current recruitment status updated daily.
Clinical Trials by Shenzhen Wingor Biotechnology Co., Ltd.
NCT07775391 Phase 1, Phase 2
Recruiting
Phase Ⅰ/Ⅱa Trial Evaluating Intravenous hUC-MSCs Injection for Safety, Tolerability and Efficacy in Patients With POI
Premature Ovarian Insufficiency
NCT07084012 Phase 2
Recruiting
A Phase IIa Clinical Trial to Evaluate the Efficacy and Safety of Intravenous Infusion of hUC-MSCs in Patients With AIS
Acute Ischemic Stroke AIS
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology